OncoCyte Corp/ US68235C2061 /
2024-07-26 9:45:31 PM | Chg. +0.06 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
3.36USD | +1.82% | 734 Turnover: 2,443.84 |
-Bid Size: - | -Ask Size: - | 3.37 | 3.31 |
GlobeNewswire
06-24
Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Lea...
GlobeNewswire
06-03
Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study
GlobeNewswire
05-30
Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine
GlobeNewswire
05-07
PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Ma...
GlobeNewswire
04-12
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Un...
GlobeNewswire
2022-03-28
Oncocyte to Present New Data Confirming Association of IO Score with Response to Immunotherapy Treat...
GlobeNewswire
2022-03-10
Oncocyte Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
GlobeNewswire
2022-03-01
Oncocyte to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday March 10
GlobeNewswire
2022-02-15
Zynerba Pharmaceuticals Announces Planned Retirement of Suzanne Hanlon and Appoints Albert P. Parker...
GlobeNewswire
2022-01-18
Oncocyte Announces Development and Co-Marketing Agreement with Thermo Fisher Scientific to Expand Ac...